Is SEE undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6
Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SEE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SEE (£0.04) is trading below our estimate of fair value (£0.29)
Significantly Below Fair Value: SEE is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SEE?
Key metric: As SEE is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for SEE. This is calculated by dividing SEE's market cap by their current
revenue.
What is SEE's PS Ratio?
PS Ratio
2.8x
Sales
US$67.63m
Market Cap
US$181.99m
SEE key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Sales vs Industry: SEE is expensive based on its Price-To-Sales Ratio (2.8x) compared to the UK Electronic industry average (1.4x).
Price to Sales Ratio vs Fair Ratio
What is SEE's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
SEE PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
2.8x
Fair PS Ratio
2.8x
Price-To-Sales vs Fair Ratio: SEE is expensive based on its Price-To-Sales Ratio (2.8x) compared to the estimated Fair Price-To-Sales Ratio (2.8x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst SEE forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
UK£0.035
UK£0.091
+157.0%
23.9%
UK£0.11
UK£0.069
n/a
2
Dec ’25
UK£0.032
UK£0.092
+183.4%
24.0%
UK£0.11
UK£0.07
n/a
2
Nov ’25
UK£0.039
UK£0.092
+134.8%
24.0%
UK£0.11
UK£0.07
n/a
2
Oct ’25
UK£0.047
UK£0.11
+129.1%
16.1%
UK£0.13
UK£0.091
n/a
3
Sep ’25
UK£0.052
UK£0.11
+105.4%
15.9%
UK£0.13
UK£0.09
n/a
3
Aug ’25
UK£0.046
UK£0.11
+128.3%
16.8%
UK£0.13
UK£0.088
n/a
3
Jul ’25
UK£0.044
UK£0.12
+167.4%
10.4%
UK£0.13
UK£0.10
n/a
3
Jun ’25
UK£0.048
UK£0.12
+155.5%
16.1%
UK£0.15
UK£0.10
n/a
3
May ’25
UK£0.044
UK£0.12
+179.6%
16.5%
UK£0.15
UK£0.10
n/a
3
Apr ’25
UK£0.049
UK£0.12
+150.9%
16.8%
UK£0.15
UK£0.10
n/a
3
Mar ’25
UK£0.049
UK£0.12
+152.5%
16.8%
UK£0.15
UK£0.10
n/a
3
Feb ’25
UK£0.054
UK£0.12
+125.7%
16.0%
UK£0.15
UK£0.10
n/a
3
Jan ’25
UK£0.054
UK£0.12
+131.1%
16.6%
UK£0.15
UK£0.10
n/a
3
Dec ’24
UK£0.055
UK£0.12
+125.0%
16.8%
UK£0.15
UK£0.10
UK£0.032
3
Nov ’24
UK£0.052
UK£0.12
+141.4%
17.0%
UK£0.15
UK£0.10
UK£0.039
3
Oct ’24
UK£0.054
UK£0.11
+105.8%
11.1%
UK£0.12
UK£0.10
UK£0.047
2
Sep ’24
UK£0.059
UK£0.15
+152.0%
36.7%
UK£0.24
UK£0.096
UK£0.052
4
Aug ’24
UK£0.054
UK£0.15
+176.0%
34.9%
UK£0.23
UK£0.10
UK£0.046
4
Jul ’24
UK£0.054
UK£0.15
+176.9%
31.8%
UK£0.24
UK£0.099
UK£0.044
5
Jun ’24
UK£0.057
UK£0.15
+161.5%
32.2%
UK£0.24
UK£0.097
UK£0.048
5
May ’24
UK£0.059
UK£0.16
+165.7%
30.9%
UK£0.23
UK£0.099
UK£0.044
4
Apr ’24
UK£0.057
UK£0.16
+172.7%
30.9%
UK£0.23
UK£0.099
UK£0.049
4
Mar ’24
UK£0.074
UK£0.16
+120.7%
31.0%
UK£0.24
UK£0.099
UK£0.049
4
Feb ’24
UK£0.069
UK£0.17
+142.0%
30.6%
UK£0.24
UK£0.10
UK£0.054
4
Jan ’24
UK£0.061
UK£0.17
+172.3%
31.4%
UK£0.25
UK£0.10
UK£0.054
4
Dec ’23
UK£0.064
UK£0.17
+160.8%
31.4%
UK£0.25
UK£0.10
UK£0.055
4
Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.